Following final government approval, 360biolabs, a BioAgilytix company, adds world-class virology & immunology expertise and LC/MS/MS small molecule capabilities to the company, enabling support of bioanalytical services across all geographies…
Alliance to strengthen both companies’ ability to provide a seamless, full-service bioanalytical client experience across the full spectrum of lifecycle developmentDurham, NC, October 4, 2021 – BioAgilytix Labs, LLC (BioAgilytix), a leading…
Ranked No. 1939, With 3-Year Revenue Growth of 230 Percent DURHAM, NC, August 25, 2021 – BioAgilytix Labs, LLC (BioAgilytix), a leading global contract research organization focused on supporting pharmaceutical…
Highly complementary transaction strengthens BioAgilytix’s ability to support bioanalytical services across all major therapeutics in development; adds LC/MS/MS capabilities; and expands team of seasoned scientistsDurham, NC, August 18, 2021 –…
Highly complementary transaction will strengthen company’s ability to support bioanalytical services across all stages, development capabilities and geographiesDurham, NC, August 16, 2021 – BioAgilytix Labs, LLC (BioAgilytix), a leading global contract research laboratory focused…
DURHAM, North Carolina – BioAgilytix, a leading bioanalytical laboratory specializing in large molecule bioanalysis, welcomes Amanda L. Hays, Ph.D. to its team as Scientific Officer. Dr. Hays will provide consultative…
BOSTON, Massachusetts – BioAgilytix, a leading bioanalytical laboratory specializing in large molecule bioanalysis, recently held a ribbon-cutting to celebrate the large-scale expansion of its leading-edge Boston laboratory. Located in the…
In this episode of Carolina Business Review, BioAgilytix CEO Jim Datin gets interviewed by PBS Charlotte with the other panel guests Carl Blackstone and Brian Etheridge.
HAMBURG, GERMANY: Jan 13, 2021 – BioAgilytix is thrilled to announce that our European lab in Hamburg, Germany is now CIR approved for 2020, 2021 and 2022, which allows us…
In this news article, TBJ covers in depth the history and achievements of BioAgilytix’ CEO, Jim Datin. He has been at the helm of BioAgilytix since November 2013 and has…
Services
Platforms